Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Buckner

Showing results (511-520 of 525) with videos related to

Pageof 53
Sort By:
Blood|February 1, 1982
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patientsR Storb, K C Doney, E D Thomas, et al.
Blood|December 1, 1976
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from SeattleR Storb, E D Thomas, P L Weiden, et al.
Annals of Internal Medicine|April 1, 1983
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblingsR Storb, R L Prentice, K M Sullivan, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Blood|April 1, 1977
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationE D Thomas, C D Buckner, M Banaji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Cancer Research|March 17, 2007
Inactivation of Apc in the mouse prostate causes prostate carcinomaKatia J Bruxvoort, Holli M Charbonneau, Troy A Giambernardi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Pageof 53

Showing results (511-520 of 525) with videos related to

Sort By:
Pageof 53
Blood|February 1, 1982
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patientsR Storb, K C Doney, E D Thomas, et al.
Blood|December 1, 1976
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from SeattleR Storb, E D Thomas, P L Weiden, et al.
Annals of Internal Medicine|April 1, 1983
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblingsR Storb, R L Prentice, K M Sullivan, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Blood|April 1, 1977
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationE D Thomas, C D Buckner, M Banaji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Cancer Research|March 17, 2007
Inactivation of Apc in the mouse prostate causes prostate carcinomaKatia J Bruxvoort, Holli M Charbonneau, Troy A Giambernardi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Pageof 53